Soft, conformal wireless optoelectronic systems for the long-term neuromodulation of bladder function
用于膀胱功能长期神经调节的柔软、共形无线光电系统
基本信息
- 批准号:9744141
- 负责人:
- 金额:$ 12.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-25 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnti-Inflammatory AgentsAnti-inflammatoryBladderBladder ControlBladder DiseasesBladder DysfunctionBlood flowChronicCollaborationsDeteriorationDevelopmentDevicesDiseaseElectric StimulationElectrodesEsthesiaFeedbackGene DeliveryGoalsHealthInflammationInflammation MediatorsInterstitial CystitisLightMaintenanceMeasurementMeasuresMechanicsMediator of activation proteinMicrofluidicsModalityMonitorNerveNeurogenic BladderNeuronsOpticsOrganOveractive BladderPathologyPerformancePeripheralPeripheral NervesPositioning AttributePumpRegulationSensorySourceSystemTechnologyTemperatureTherapeuticThinnessTimeTissuesUnited StatesVisceralWireless TechnologyWorkbasebladder paindesignflexibilityimprovedinsightminimally invasiveneuroinflammationneuronal circuitryneuroregulationnew technologynoveloptogeneticsprogramsrelating to nervous systemremote controlsensorsuccesstool
项目摘要
Abstract
Bladder pain and dysfunction are sources of profound debilitation for millions of people in the United States
with interstitial cystitis/bladder pain syndrome, overactive bladder, and neurogenic bladder. Current treatments
for these disorders are ineffective and do not address the underlying pathology. A substantial barrier to the
development of improved therapeutics is an insufficient understanding of mechanisms by which the bladder is
controlled. Progress will depend critically on the development of new technologies in neural interfaces. In
particular, a combination of optogenetic approaches along with new, wireless optoelectronic systems and
electronic hardware for nerve recording and electrical stimulation will provide a unique set of tools for
enhanced insights into peripheral organ control. Additionally, the ability to measure, in real-time, neural
inflammation and to programmably deliver local anti-inflammatory agents at the neural interface will not only
allow robust, high performance chronic integration, but also further the understanding of maintenance at nerve-
device interfaces in other applications. In this proposal, we develop a suite of soft, fully-implantable microscale
devices with advanced design features specifically configured to minimize and mitigate inflammation for
essentially permanent integration with the targeted nerves. In Aim 1, we propose to integrate optogenetic
technologies with fully-implantable wireless systems for inhibition of peripheral neurons innervating the
bladder. In Aim 2, we propose to integrate ultra-thin, flexible electrode technology and novel neuroinflammatory
monitors to the wireless control of bladder peripheral nerves. In Aim 3, we integrate a fully-implantable,
wirelessly programmable microfluidic platform for closed-loop maintenance of the chronic nerve interface. Our
collaborative team has extensive success merging technologies into unified multi-modal devices and
subsequently applying them to the mechanistic study of neuronal subpopulations. The technology produced
by these aims will be optimally positioned to study mechanisms of control of end-organ function, and to do so
in a way that is minimally invasive.
摘要
膀胱疼痛和功能障碍是美国数百万人严重衰弱的原因
间质性膀胱炎/膀胱疼痛综合征、膀胱过度活动症和神经源性膀胱。当前治疗
对于这些疾病是无效的,并且不能解决潜在的病理学。一个实质性的障碍,
改进的治疗方法的发展是对膀胱炎的机制的理解不足,
控制。进展将主要取决于神经接口新技术的发展。在
特别是,光遗传学方法与新的无线光电系统的组合沿着,
用于神经记录和电刺激的电子硬件将提供一套独特的工具,
增强了对外周器官控制的了解。此外,能够实时测量神经
炎症并在神经界面可编程地递送局部抗炎剂不仅将
允许强大的,高性能的慢性整合,但也进一步了解维护神经,
其他应用中的设备接口。在这个提议中,我们开发了一套柔软的,完全可植入的微型
具有先进设计特征的器械,专门配置用于最大限度地减少和减轻炎症,
与目标神经基本上永久整合。在目标1中,我们建议整合光遗传学,
技术与完全植入式无线系统,用于抑制周围神经元支配
膀胱在目标2中,我们提出将超薄柔性电极技术和新型神经炎性
监测器到膀胱周围神经的无线控制。在目标3中,我们整合了一个完全可植入的,
无线可编程微流体平台,用于慢性神经界面的闭环维护。我们
协作团队在将技术融合到统一的多模式设备中方面取得了广泛的成功,
随后将其应用于神经元亚群的机制研究。所产生的技术
通过这些目标,将最佳地定位于研究终末器官功能的控制机制,并且这样做
以一种微创的方式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert W Gereau其他文献
Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-κB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine
- DOI:
10.1186/1744-8069-2-20 - 发表时间:
2006-06-09 - 期刊:
- 影响因子:2.800
- 作者:
Santina Chiechio;Agata Copani;Laura De Petris;Maria Elena P Morales;Ferdinando Nicoletti;Robert W Gereau - 通讯作者:
Robert W Gereau
Robert W Gereau的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert W Gereau', 18)}}的其他基金
Functional and genetic characterization of human DRG and spinal cord at single cell resolution
单细胞分辨率下人类 DRG 和脊髓的功能和遗传特征
- 批准号:
10593847 - 财政年份:2022
- 资助金额:
$ 12.73万 - 项目类别:
INTERCEPT: Integrated Research Center for human Pain Tissues
截取:人类疼痛组织综合研究中心
- 批准号:
10707405 - 财政年份:2022
- 资助金额:
$ 12.73万 - 项目类别:
Functional and genetic characterization of human DRG and spinal cord at single cell resolution
单细胞分辨率下人类 DRG 和脊髓的功能和遗传特征
- 批准号:
10707419 - 财政年份:2022
- 资助金额:
$ 12.73万 - 项目类别:
INTERCEPT: Integrated Research Center for human Pain Tissues
截取:人类疼痛组织综合研究中心
- 批准号:
10593843 - 财政年份:2022
- 资助金额:
$ 12.73万 - 项目类别:
Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths
开发用于输送纳洛酮的植入式闭环系统,以预防阿片类药物相关的过量死亡
- 批准号:
10022117 - 财政年份:2019
- 资助金额:
$ 12.73万 - 项目类别:
Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths
开发用于输送纳洛酮的植入式闭环系统,以预防阿片类药物相关的过量死亡
- 批准号:
10456452 - 财政年份:2019
- 资助金额:
$ 12.73万 - 项目类别:
Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths
开发用于输送纳洛酮的植入式闭环系统,以预防阿片类药物相关的过量死亡
- 批准号:
9902945 - 财政年份:2019
- 资助金额:
$ 12.73万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 12.73万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 12.73万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 12.73万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 12.73万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 12.73万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 12.73万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 12.73万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 12.73万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 12.73万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 12.73万 - 项目类别:














{{item.name}}会员




